anmelden
SMI Equal Weight
372,28
PKT
-0,21
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.04.05 | Swiss Life Sell | Merck Finck & Co | |
| 06.04.05 | Swiss Life Accumulate | Helvea | |
| 07.04.05 | Swiss Life Overweight | Lehman Brothers | |
| 06.04.05 | Swiss Life Overweight | JP Morgan | |
| 07.04.05 | Swiss Life Neutral | Sarasin Research | |
| 06.04.05 | Zurich Insurance Outperform | Goldman Sachs | |
| 05.04.05 | Zurich Insurance Buy | Sarasin Research | |
| 04.04.05 | Givaudan Neutral | Sarasin Research | |
| 04.04.05 | Swiss Life Overweight | JP Morgan | |
| 04.04.05 | Swiss Life Neutral | Sarasin Research | |
| 01.04.05 | Swisscom Neutral | Helvea | |
| 01.04.05 | Swiss Life Outperform | HypoVereinsbank | |
| 31.03.05 | Swiss Life Overweight | Lehman Brothers | |
| 30.03.05 | Swisscom Neutral | Sarasin Research | |
| 29.03.05 | Roche Buy | Sarasin Research | |
| 24.03.05 | Roche Sector Outperform | Vontobel | |
| 24.03.05 | Swisscom Neutral | Sarasin Research | |
| 22.03.05 | UBS Buy | Merrill Lynch | |
| 22.03.05 | ABB (Asea Brown Boveri) Overweight | JP Morgan | |
| 22.03.05 | Roche Buy | Sarasin Research | |
| 23.03.05 | UBS Neutral | Merrill Lynch | |
| 21.03.05 | Holcim Neutral | Sarasin Research | |
| 22.03.05 | Swisscom Neutral | Helvea | |
| 22.03.05 | Geberit Reduce | Helvea | |
| 22.03.05 | Novartis Accumulate | Helvea | |
| 21.03.05 | ABB (Asea Brown Boveri) Neutral | Sarasin Research | |
| 22.03.05 | Holcim Accumulate | Helvea | |
| 21.03.05 | Novartis Kaufen | Helaba Trust | |
| 22.03.05 | ABB (Asea Brown Boveri) Accumulate | Helvea | |
| 21.03.05 | Novartis Neutral | Sarasin Research | |
| 21.03.05 | Geberit Market Outperform | Vontobel | |
| 21.03.05 | Novartis Neutral | Sarasin Research | |
| 17.03.05 | UBS Buy | Helvea | |
| 18.03.05 | ABB (Asea Brown Boveri) Overweight | Lehman Brothers | |
| 18.03.05 | Geberit Reduce | Helvea | |
| 16.03.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 17.03.05 | Roche In-Line | Goldman Sachs | |
| 16.03.05 | Swiss Life Sell | Merck Finck & Co | |
| 17.03.05 | Novartis Outperform | Goldman Sachs | |
| 17.03.05 | Roche Buy | Helvea |